Phase I/II Combination With Irinotecan- Erbitux

Clinical trial NCT00594984 · COMPLETED

Trial details

NCT number: NCT00594984
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer (MCRC)

Start date: 2008-05-01
Primary completion: 2012-12-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.